Загрузка...
Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: British paediatric and adolescent bone group recommendations
X-linked hypophosphataemia (XLH) is caused by a pathogenic variant in the PHEX gene, which leads to elevated circulating FGF23. High FGF23 causes hypophosphataemia, reduced active vitamin D concentration and clinically manifests as rickets in children and osteomalacia in children and adults. Convent...
Сохранить в:
| Опубликовано в: : | Endocr Connect |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Bioscientifica Ltd
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7707830/ https://ncbi.nlm.nih.gov/pubmed/33112809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-20-0291 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|